Forget short-term pressure; in the long term, the right business is what pays: 5 mid-cap stocks with an upside potential of up to 36%We have said this before, and we say it again: No one can predict when the market will bottom out. You can see the bottom only in hindsight...
27 Oct, 2026, 03.02 PM IST
Cipla Q2 Results: Profit falls 35% YoY to Rs 878 crore; revenue slips 2%Cipla reported a 35% drop in consolidated net profit for Q2FY27, which stood at Rs 878 crore. The company also experienced a 2.4% year-on-y...
27 Oct, 2026, 01.54 PM IST
D-Street in gloomy mood, but Kotak sees 3 triggers for rebounds and adds 5 midcap stocks to portfolioDalal Street faces significant market challenges, leading Kotak Institutional Equities to spotlight selective stock value. With large-cap s...
27 Oct, 2026, 01.37 PM IST
Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...
27 Oct, 2026, 12.55 PM IST
Stocks in news: Paytm, Tata Consumer, Dalmia Bharat, REC and DCM ShriramIndian equity markets showed recovery with a rise in NSE Nifty 50, ending a four-session losing streak. Several companies reported their Se...
27 Oct, 2026, 06.00 AM IST
Two Trades for Today: A top pharma company for a 5.3% upmove, a mid-cap chemical maker’s stock for an almost 7% riseOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
26 Oct, 2026, 07.51 PM IST
Sugar stocks: Short-term pain is real; has the long-term case broken? 7 stocks from the sugar-ethanol ecosystemThough this year's ethanol tender leaves sugar out, the long-term blending roadmap still points to rising ethanol use. The move is aimed at...
26 Oct, 2026, 07.24 PM IST
Coforge slips 3% even as Jefferies, Nomura, others raise targets after Q2 earnings. Why are they bullish?Coforge shares fell despite strong Q2 results and brokerages raising target prices. Net profit surged 56.5% year-on-year to Rs 588.1 crore,...
26 Oct, 2026, 09.57 AM IST
IndusInd Bank shares rise 2% after Q2 results. Why Jefferies cut target price despite lender swinging to profitIndusInd Bank announced a net profit of Rs 1,176 crore for the quarter ending September 2027. The bank's asset quality improved with gross ...
26 Oct, 2026, 09.26 AM IST
Two Trades for Today: A digital tech solutions company for a 5.4% rise, a top pharma stock for an almost 7% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
25 Oct, 2026, 01.29 PM IST
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruptionDr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda i...
23 Oct, 2026, 03.19 PM IST
How Vivek Ramaswamy built his billion-dollar fortune through biotech, stock sales and investments — and what he still ownsVivek Ramaswamy's Net Worth: Vivek Ramaswamy’s estimated $2.2 billion to $2.3 billion fortune was built through biotech deals, stock sales ...
23 Oct, 2026, 01.35 AM IST
Two Trades for Today: A top pharma company for a 6.3% upmove, a large-cap hospitality stock for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
22 Oct, 2026, 11.47 PM IST
Every bad cycle ends the same way; problems find their own solutions: 5 large-cap stocks with upside potential of up to 27%What should you focus on when headwinds blow? Not the share price, and not the morning's news. It should be the business and the quality of...
22 Oct, 2026, 04.46 PM IST
Why did market fall today? Sensex drops 460 points, Nifty closes below 22,700. Key factors behind Rs 3 lakh crore routThe Indian stock market took a notable hit on Thursday, with Sensex and Nifty reporting steep declines. This drop coincided with rising oil...
22 Oct, 2026, 03.57 PM IST
Sun Pharma to raise Rs 10,000 crore to part-finance Organon dealSun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance b...
21 Oct, 2026, 06.48 AM IST
Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stocks to watchIndia's CRDMO sector is on the brink of expansion, backed by solid partnerships with major pharmaceutical players and comprehensive capabil...
13 Oct, 2026, 10.10 AM IST